目录
- The breakthrough in primary human hepatocytes in vitro expansion
- Next-generation sequencing and its clinical application
- Circular RNAs and human glioma
- Qidong: a crucible for studies on liver cancer etiology and prevention
- The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility
- Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways
- Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
- p53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis
- STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression
- Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients
- Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
- BRAFV600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
- Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma
- Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis
- 68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
- Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study
- Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
- Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study
- Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
- Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma